Literature DB >> 17151875

Obesity and other clinical endpoints in steroid-sensitive nephrotic syndrome.

Thomas J Neuhaus, Eva-Maria Rüth, Markus Kemper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17151875     DOI： 10.1007/s00467-006-0362-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Risk factors for glucocorticoid-induced obesity in children with steroid-sensitive nephrotic syndrome.

Authors:  Bethany J Foster; Justine Shults; Babette S Zemel; Mary B Leonard
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

2.  Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome.

Authors:  Eva-Maria Rüth; Markus J Kemper; Ernst P Leumann; Guido F Laube; Thomas J Neuhaus
Journal:  J Pediatr       Date:  2005-08       Impact factor: 4.406

3.  Reduced bone mineral density in adults treated with high-dose corticosteroids for childhood nephrotic syndrome.

Authors:  Janet Hegarty; M Zulf Mughal; Judith Adams; Nicholas J A Webb
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612
  3 in total
  1 in total

1.  Effect of obesity on response to cardiovascular drugs in pediatric patients with renal disease.

Authors:  Sherif Hanafy; Maury Pinsk; Fakhreddin Jamali
Journal:  Pediatr Nephrol       Date:  2008-12-13       Impact factor: 3.714
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.